These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 21322752)

  • 1. Adoptive T-cell immunotherapy using T-cell receptor gene transfer: aiming at a cure for cancer.
    Yasukawa M; Ochi T; Fujiwara H
    Immunotherapy; 2011 Feb; 3(2):135-40. PubMed ID: 21322752
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic redirection of T cells for cancer therapy.
    Westwood JA; Kershaw MH
    J Leukoc Biol; 2010 May; 87(5):791-803. PubMed ID: 20179152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adoptive T-cell therapy of cancer.
    Yee C
    Hematol Oncol Clin North Am; 2006 Jun; 20(3):711-33. PubMed ID: 16762731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetically modified immune cells for cancer immunotherapy.
    Jiang L; Wang W
    Sci China Life Sci; 2018 Oct; 61(10):1277-1279. PubMed ID: 30276708
    [No Abstract]   [Full Text] [Related]  

  • 5. Regional Infusion of Chimeric Antigen Receptor T Cells to Overcome Barriers for Solid Tumor Immunotherapy.
    Hardaway JC; Prince E; Arepally A; Katz SC
    J Vasc Interv Radiol; 2018 Jul; 29(7):1017-1021.e1. PubMed ID: 29935783
    [No Abstract]   [Full Text] [Related]  

  • 6. [Adoptive immunotherapy using gene-modified T cells to express target-specific receptors against hematological malignancy].
    Fujiwara H
    Rinsho Ketsueki; 2014 Oct; 55(10):2162-74. PubMed ID: 25297783
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cellular immunotherapy of cancer].
    Kawakami Y
    Rinsho Ketsueki; 2003 Jun; 44(6):358-67. PubMed ID: 12884813
    [No Abstract]   [Full Text] [Related]  

  • 8. Preclinical development of T cell receptor gene therapy.
    Bendle GM; Haanen JB; Schumacher TN
    Curr Opin Immunol; 2009 Apr; 21(2):209-14. PubMed ID: 19321326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adoptive cellular immunotherapy for childhood malignancies.
    Cooper LJ
    Bone Marrow Transplant; 2008 Jan; 41(2):183-92. PubMed ID: 18026145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen choice in adoptive T-cell therapy of cancer.
    Offringa R
    Curr Opin Immunol; 2009 Apr; 21(2):190-9. PubMed ID: 19297140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adoptive cancer immunotherapy using genetically engineered designer T-cells: First steps into the clinic.
    Eshhar Z
    Curr Opin Mol Ther; 2010 Feb; 12(1):55-63. PubMed ID: 20140817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status and future applications of cellular therapies for cancer.
    Copier J; Bodman-Smith M; Dalgleish A
    Immunotherapy; 2011 Apr; 3(4):507-16. PubMed ID: 21463192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The cutting edge of antitumor adoptive cell therapy].
    Nakatsugawa M; Yamashita Y; Hirano N
    Rinsho Ketsueki; 2011 Oct; 52(10):1713-20. PubMed ID: 21971251
    [No Abstract]   [Full Text] [Related]  

  • 14. T-cell therapy for cancer.
    Barrett J; Bollard CM
    Immunotherapy; 2012 Apr; 4(4):347-50. PubMed ID: 22512624
    [No Abstract]   [Full Text] [Related]  

  • 15. Current status of genetic modification of T cells for cancer treatment.
    Dotti G; Heslop HE
    Cytotherapy; 2005; 7(3):262-72. PubMed ID: 16081353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Redirected T cell-based antileukemia adoptive immunotherapy using tumor antigen-specific TCR gene transfer].
    Fujiwara H
    Rinsho Ketsueki; 2014 Jun; 55(6):657-69. PubMed ID: 24975335
    [No Abstract]   [Full Text] [Related]  

  • 17. Functional design of chimeric T-cell antigen receptors for adoptive immunotherapy of cancer: architecture and outcomes.
    Shirasu N; Kuroki M
    Anticancer Res; 2012 Jun; 32(6):2377-83. PubMed ID: 22641678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods to edit T cells for cancer immunotherapy.
    Lucibello F; Menegatti S; Menger L
    Methods Enzymol; 2020; 631():107-135. PubMed ID: 31948544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invariant natural killer T cells in immune surveillance and tumor immunotherapy: perspectives and potentials.
    Haeryfar SM
    Arch Iran Med; 2008 Mar; 11(2):186-95. PubMed ID: 18298297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chimeric Antigen Receptor T-Cells: Successful Translation of the First Cell and Gene Therapy From Bench to Bedside.
    Rodriguez-Cartagena LG; Bowles BS; Kurani SS; Windebank AJ; Kenderian SS; Greenberg-Worisek AJ
    Clin Transl Sci; 2018 Nov; 11(6):537-539. PubMed ID: 30242965
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.